Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)
GENKYST
1 other identifier
observational
4,000
1 country
26
Brief Summary
Genkyst is a regional cohort involving up to nephrologists working in private and public nephrology centers in the West of France. It registers clinical and molecular genetic data of all consenting patients with ADPKD from this area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 30, 2016
CompletedFirst Posted
Study publicly available on registry
September 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedSeptember 2, 2016
August 1, 2016
9.6 years
August 30, 2016
September 1, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical description of the patient
at the inclusion day
Secondary Outcomes (1)
Genetic analysis
at the inclusion day
Eligibility Criteria
ADPKD patients followed in Nephrology centers in the West of France
You may qualify if:
- ADPKD patients followed in Nephrology centers in the West of France
- Age \>17
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
AUB Brest
Brest, France, 29200, France
ECHO dialyse
Le Mans, France, 72016, France
CH Niort
Niort, France, 79021, France
ECHO Confluent
Rezé, France, 44402, France
CH de Saint Nazaire
Saint-Nazaire, France, 44606, France
CH Saint Malo
St-Malo, France, 35403, France
CHU Angers
Angers, 49933, France
CHU Brest
Brest, 29200, France
Centre Nephrologie et Dialyse d Armorique
Brest, 29283, France
CH La Roche Sur Yon
La Roche-sur-Yon, 85925, France
CH Le Mans
Le Mans, 72037, France
AUB Lorient
Lorient, 56100, France
CH Bretagne Sud
Lorient, 56322, France
AUB Morlaix
Morlaix, 29600, France
CHU Nantes
Nantes, 44093, France
CHU Poitiers
Poitiers, 86021, France
CH Centre Bretagne
Pontivy, 56300, France
AUB Quimper
Quimper, 29107, France
CHI de Cournouaille
Quimper, 29107, France
CHU Rennes
Rennes, 35033, France
Centre Heliomarin de Roscoff
Roscoff, 29684, France
CH Yves LE FOLL
Saint-Brieuc, 22023, France
ECHO Centre Ambulatoire
Saint-Herblain, 44821, France
CHU Tours
Tours, 37044, France
CH Bretagne Atlantique
Vannes, 56017, France
ECHO Vannes
Vannes, 56017, France
Biospecimen
whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yannick Le Meur, MD PhD
University Hospital, Brest
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2016
First Posted
September 2, 2016
Study Start
June 1, 2010
Primary Completion
January 1, 2020
Last Updated
September 2, 2016
Record last verified: 2016-08